New York Life Ventures Research
Investment Thesis
New York Life Ventures (NYL Ventures) is the corporate venture capital arm of New York Life Insurance Company, the largest mutual life insurance company in the United States. Founded in 2012 and headquartered in New York City, NYL Ventures operates as a dual-purpose investor: a financial investor targeting top-quartile returns and a strategic investor that connects portfolio companies to New York Life's distribution network, actuarial expertise, and relationships across insurance and wealth management. The fund has grown to roughly $1.2 billion in assets under management, reporting a 10-year internal rate of return near 30%. Because it invests off its parent's balance sheet rather than a traditional LP-backed fund vehicle, NYL Ventures can hold longer time horizons and prioritize strategic fit alongside financial return.
Sector Focus
NYL Ventures concentrates on:
- Fintech and financial services infrastructure
- Insurtech (life, health, and P&C insurance technology)
- Enterprise software and SaaS, with growing emphasis on applied AI and agentic workflow tools
- Digital health and healthtech/wellness platforms
- Proptech and real estate technology
- Legal and regulatory technology (AI-driven compliance)
The firm has leaned increasingly into AI and "deep tech" investments over the past two years, backing regulatory-AI and workflow-AI platforms (Norm Ai, Scribe, QueryStory) alongside its historical fintech/insurtech core.
Stage Focus
NYL Ventures invests from seed through growth stage, with the bulk of activity concentrated in Series A and Series B. It participates as both a lead and a follower depending on the deal, frequently investing alongside specialist financial-services and health-tech VCs (Thrive Capital, SignalFire, F-Prime Capital, Brewer Lane Ventures) rather than leading rounds outright.
Check Size
Typical check size ranges from $1 million to over $10 million, scaling with stage. Recent disclosed round sizes the firm has participated in span roughly $6M (QueryStory seed) to $75M (Scribe Series C).
Lead Tendency
NYL Ventures more often participates alongside a lead investor than leads itself — recent rounds (Modern Life, Dispatch, Wellth, Scribe) were each led by other firms (Thrive Capital, Brewer Lane Ventures, Mercato Partners, StepStone Group respectively), with NYL Ventures as a strategic participant.
Recent Activity
NYL Ventures made roughly 4 disclosed investments in 2025 and has been most active in fintech/insurtech and AI-driven enterprise software:
- November 2025: Participated in Scribe's $75M Series C (workflow AI platform, $1.3B valuation), led by StepStone Group
- November 2025: Participated in Modern Life's $20M Series A (AI-powered life insurance brokerage), led by Thrive Capital
- December 2025: Participated in QueryStory's $6M seed round (enterprise data analysis platform)
- September 2025: Participated in Dispatch's $18M Series A (data orchestration for financial advisors), led by Brewer Lane Ventures
- August 2025: Participated in Wellth's $36M Series C (AI-powered patient behavior-change platform for health plans), led by Mercato Partners
- June 2026: Portfolio company Strata Identity (identity orchestration) was acquired by Rubrik
Portfolio Highlights
NYL Ventures has completed 40+ VC investments since inception, with roughly 34 active portfolio companies including 4 unicorns, 1 IPO, and 10 acquisitions/exits. Notable exits include Netskope (security, IPO), DataRobot (enterprise AI, acquired), and Personal Capital (wealthtech, acquired by Empower). Current notable holdings span AI/compliance (Norm Ai), model risk management (ValidMind), grief/bereavement benefits (Empathy), and workflow AI (Scribe, now a unicorn at $1.3B valuation).
Team
- Joel Albarella — Senior Vice President, Head of NYL Ventures. Leads the firm's dual strategic/financial investing mandate on behalf of New York Life.
- Tim Del Bello — Head of Investments. Oversees deal sourcing and investment decisions across the portfolio.
- John Masson — Director. Works across diligence and portfolio company support.
- Madison Cuthbertson — Senior Associate.
- Alan Day — Senior Associate.
The team is reported at roughly 14 members including partners and principals, based in New York.
Decision Process
As a corporate venture arm, decisions run through an internal investment team led by Joel Albarella, with strategic-fit review tied to New York Life's core insurance and wealth management businesses. Treated here as an investment-committee-style process given the corporate structure, though exact governance details are not publicly disclosed.
Founder Preferences
NYL Ventures favors founders building in regulated, complex verticals (insurance, financial services, healthcare) where the firm's strategic distribution and actuarial relationships add differentiated value beyond capital — particularly technical teams applying AI to compliance, underwriting, and workflow automation.
Geographic Focus
Primarily United States, headquartered in New York City (51 Madison Avenue), with portfolio companies concentrated in major U.S. tech hubs (New York, San Francisco Bay Area).